Lords Mark Industries Expands Silvassa Plant, Secures US FDA Nod

Lords Mark Industries Limited has completed its Silvassa manufacturing expansion ahead of schedule, positioning itself for international growth. The company has become Asia's first to secure US FDA registration for over 200 surgical, medical-care, and hygiene products. Exports to the United States are slated to begin in December 2026. The expansion also prepares the company to explore opportunities in South America. This strategic move aims to leverage India's manufacturing capabilities for a scalable export business in the global healthcare market, targeting significant growth in the US and South American surgical devices markets.